Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Flaherty

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
ERJ Open Research|December 3, 2024
Acute exacerbations in patients with progressive pulmonary fibrosisMichael Kreuter, Elizabeth A Belloli, Elisabeth Bendstrup, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2019
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary FibrosisRobert P Dickson, Gary B Huffnagle, Kevin R Flaherty, et al.
Chest|October 19, 2020
Association Between Anticoagulation and Survival in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Patient RegistryChristopher S King, Elizabeth Freiheit, A Whitney Brown, et al.
The European Respiratory Journal|June 28, 2018
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosisKevin R Flaherty, Charlene D Fell, J Terrill Huggins, et al.
Chest|November 16, 2013
Predicting pulmonary fibrosis disease course from past trends in pulmonary functionShelley L Schmidt, Nabihah Tayob, Meilan K Han, et al.
Chest|October 2, 2015
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function DeclineMargaret L Salisbury, Meng Xia, Yueren Zhou, et al.
ERJ Open Research|May 25, 2023
External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosisAbhimanyu Chandel, Christopher S King, Rosalinda V Ignacio, et al.
Annals of the American Thoracic Society|June 30, 2021
Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi SurveyAlan K Y Teoh, Anne E Holland, Julie Morisset, et al.
Molecular Medicine (Cambridge, Mass.)|May 27, 2003
A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumoniaKevin K Kim, Kevin R Flaherty, Qi Long, et al.
The American Journal of Surgical Pathology|June 17, 2005
Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 casesJunya Fukuoka, Teri J Franks, Thomas V Colby, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
ERJ Open Research|December 3, 2024
Acute exacerbations in patients with progressive pulmonary fibrosisMichael Kreuter, Elizabeth A Belloli, Elisabeth Bendstrup, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2019
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary FibrosisRobert P Dickson, Gary B Huffnagle, Kevin R Flaherty, et al.
Chest|October 19, 2020
Association Between Anticoagulation and Survival in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Patient RegistryChristopher S King, Elizabeth Freiheit, A Whitney Brown, et al.
The European Respiratory Journal|June 28, 2018
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosisKevin R Flaherty, Charlene D Fell, J Terrill Huggins, et al.
Chest|November 16, 2013
Predicting pulmonary fibrosis disease course from past trends in pulmonary functionShelley L Schmidt, Nabihah Tayob, Meilan K Han, et al.
Chest|October 2, 2015
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function DeclineMargaret L Salisbury, Meng Xia, Yueren Zhou, et al.
ERJ Open Research|May 25, 2023
External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosisAbhimanyu Chandel, Christopher S King, Rosalinda V Ignacio, et al.
Annals of the American Thoracic Society|June 30, 2021
Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi SurveyAlan K Y Teoh, Anne E Holland, Julie Morisset, et al.
Molecular Medicine (Cambridge, Mass.)|May 27, 2003
A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumoniaKevin K Kim, Kevin R Flaherty, Qi Long, et al.
The American Journal of Surgical Pathology|June 17, 2005
Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 casesJunya Fukuoka, Teri J Franks, Thomas V Colby, et al.
Pageof 21